Indoleamine 2,3-dioxygenase-expressing myeloid dendritic cells and macrophages in infectious and noninfectious cutaneous granulomas

Journal of the American Academy of Dermatology

Volumn 65, Issue 4, 2011, Pages 819-832

  Von Bubnoff, Dagmar ^a   Scheler, Marina ^a   Wilms, Helene ^a   Wenzel, Jörg ^a   Von Bubnoff, Nikolas ^b   Häcker, Georg ^c   Schultze, Joachim ^a   Popov, Alexey ^a   Racz, Paul ^d   Bieber, Thomas ^a   Wickenhauser, Claudia ^e  

^a UNIVERSITY OF BONN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

cutaneous granuloma; dendritic cells; granuloma annulare; indoleamine 2,3 dioxygenase; leprosy; macrophages; sarcoidosis; tuberculosis

Indexed keywords

BIOLOGICAL MARKER; CD3 ANTIGEN; CD68 ANTIGEN; GLYCOPROTEIN P 15095; INDOLEAMINE 2,3 DIOXYGENASE; PROTEIN S 100; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; ENZYME LOCALIZATION; GRANULOMA ANNULARE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LEPROSY; LUPUS VULGARIS; MACROPHAGE; MYELOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOIDOSIS; SKIN BIOPSY; SKIN GRANULOMA;

DENDRITIC CELLS; GRANULOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MACROPHAGES; MYELOID CELLS; SKIN;

EID: 80052796079     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.07.050     Document Type: Article

References (55)

1. U. Grohmann, F. Fallarino, and P. Puccetti Tolerance, DCs and tryptophan: much ado about IDO Trends Immunol 24 2003 242
2. E.R. Pfefferkorn, and P.M. Guyre Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferon Infect Immun 44 1984 211 216 (Pubitemid 14139779)
3. D.H. Munn, M. Zhou, J.T. Attwood, I. Bondarev, S.J. Conway, and B. Marshall Prevention of allogeneic fetal rejection by tryptophan catabolism Science 281 1998 1191 1193 (Pubitemid 28406294)
4. U. Grohmann, C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, and A. Falorni CTLA-4-Ig regulates tryptophan catabolism in vivo Nat Immunol 3 2002 1097 1101 (Pubitemid 35363664)
5. D. von Bubnoff, H. Matz, C. Frahnert, M.L. Rao, D. Hanau, and H. de la Salle FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responses J Immunol 169 2002 1810 1816 (Pubitemid 34857641)
6. C. Uyttenhove, L. Pilotte, I. Theate, V. Stroobant, D. Colau, and N. Parmentier Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Nat Med 9 2003 1269 1274 (Pubitemid 37279849)
7. A. Popov, and J.L. Schultze IDO-expressing regulatory dendritic cells in cancer and chronic infection J Mol Med 86 2008 145 160 (Pubitemid 351172124)
8. M.D. Sharma, B. Baban, P. Chandler, D.Y. Hou, N. Singh, and H. Yagita Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase J Clin Invest 117 2007 2570 2582 (Pubitemid 47494358)
9. M.L. Belladonna, P. Puccetti, C. Orabona, F. Fallarino, C. Vacca, and C. Volpi Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes Transplantation 84 2007 S17 S20
10. P. Terness, T.M. Bauer, L. Rose, C. Dufter, A. Watzlik, and H. Simon Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites J Exp Med 196 2002 447 457
11. M.L. Belladonna, U. Grohmann, P. Guidetti, C. Volpi, R. Bianchi, and M.C. Fioretti Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO J Immunol 177 2006 130 137 (Pubitemid 43939124)
12. D.H. Munn, M.D. Sharma, B. Baban, H.P. Harding, Y. Zhang, and D. Ron GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase Immunity 22 2005 633 642 (Pubitemid 40719198)
13. + T regulatory cells J Immunol 183 2009 145 154
14. F. Diaz-San Segundo, M.P. Moraes, T. de Los Santos, C.C. Dias, and M.J. Grubman Interferon-induced protection against foot-and-mouth disease virus correlates with enhanced tissue specific innate immune cell infiltration and interferon stimulated gene expression J Virol 84 2010 2063 2077
15. L.K. Jasperson, C. Bucher, A. Panoskaltsis-Mortari, A.L. Mellor, D.H. Munn, and B.R. Blazar Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality Blood 114 2009 5062 5070
16. F. Meloni, S. Giuliano, N. Solari, P. Draghi, S. Miserere, and A.M. Bardoni Indoleamine 2,3-dioxygenase in lung allograft tolerance J Heart Lung Transplant 28 2009 1185 1192
17. L. Jia, P. Tian, and C. Ding Immunoregulatory effects of indoleamine 2, 3-dioxygenase in transplantation Transpl Immunol 21 2009 18 22
18. M. Scheler, J. Wenzel, T. Tuting, O. Takikawa, T. Bieber, and D. von Bubnoff Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation? Am J Pathol 171 2007 1936 1943
19. T. Ulrichs, and S.H. Kaufmann New insights into the function of granulomas in human tuberculosis J Pathol 208 2006 261 269 (Pubitemid 43126118)
20. J.C. Berg, K.L. Hamacher, and G.D. Roberts Pseudomycetoma caused by Microsporum canis in an immunosuppressed patient: a case report and review of the literature J Cutan Pathol 34 2007 431 434 (Pubitemid 46633339)
21. J.I. Gallin, and K. Zarember Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease Trans Am Clin Climatol Assoc 118 2007 175 185
22. A. Popov, Z. Abdullah, C. Wickenhauser, T. Saric, J. Driesen, and F.G. Hanisch Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection J Clin Invest 116 2006 3160 3170 (Pubitemid 44878630)
23. D.S. Ridley, and W.H. Jopling A classification of leprosy for research purposes Lepr Rev 33 1962 119 128
24. D.S. Ridley Histological classification and the immunological spectrum of leprosy Bull World Health Organ 51 1974 451 465
25. L. Portillo-Gomez, S.L. Morris, and A. Panduro Rapid and efficient detection of extra-pulmonary Mycobacterium tuberculosis by PCR analysis Int J Tuberc Lung Dis 4 2000 361 370 (Pubitemid 30194113)
26. D. von Bubnoff, H. Bausinger, H. Matz, S. Koch, G. Hacker, and O. Takikawa Human epidermal Langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase J Invest Dermatol 123 2004 298 304 (Pubitemid 38951824)
27. J. Wenzel, M. Uerlich, O. Haller, T. Bieber, and T. Tueting Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod J Cutan Pathol 32 2005 257 262 (Pubitemid 40459926)
28. D. von Bubnoff, D. Hanau, J. Wenzel, O. Takikawa, B. Hall, and S. Koch Indoleamine 2,3-dioxygenase-expressing antigen-presenting cells and peripheral T-cell tolerance: another piece to the atopic puzzle? J Allergy Clin Immunol 112 2003 854 860 (Pubitemid 37412051)
29. S.K. Gupta, S. Nigam, A.K. Mandal, and V. Kumar S-100 as a useful auxiliary diagnostic aid in tuberculoid leprosy J Cutan Pathol 33 2006 482 486 (Pubitemid 44049884)
30. L.R. Goulart, and I.M. Goulart Leprosy pathogenetic background: a review and lessons from other mycobacterial diseases Arch Dermatol Res 301 2009 123 137
31. D.G. Russell Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5 2007 39 47 (Pubitemid 44942302)
32. J.L. Flynn, and J. Chan What's good for the host is good for the bug Trends Microbiol 13 2005 98 102 (Pubitemid 40311891)
33. S. Pabst, A. Karpushova, A. Diaz-Lacava, S. Herms, M. Walier, and S. Zimmer VEGF gene haplotypes are associated with sarcoidosis Chest 137 2010 156 163
34. J. Wahlstrom, J. Dengjel, O. Winqvist, I. Targoff, B. Persson, and H. Duyar Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis Clin Immunol 133 2009 353 363
35. D.R. Moller Potential etiologic agents in sarcoidosis Proc Am Thorac Soc 4 2007 465 468 (Pubitemid 47435374)
36. T. Manestar-Blazic, I. Brajac, D. Dragojevic Malnar, and M. Kastelan Granuloma annulare-a genetic disorder that sustains an incomplete foreign-body granuloma reaction Med Hypotheses 67 2006 876 878 (Pubitemid 44062127)
37. F. Vazquez-Lopez, M.A. Gonzalez-Lopez, C. Raya-Aguado, and N. Perez-Oliva Localized granuloma annulare and autoimmune thyroiditis: a new case report J Am Acad Dermatol 43 2000 943 945
38. M. Ziemer, T. Grabner, K. Eisendle, M. Baltaci, and B. Zelger Granuloma annulare-a manifestation of infection with Borrelia? J Cutan Pathol 35 2008 1050 1057
39. B.R. Smoller, K.T. Madhusudhan, M.A. Scott, and T.D. Horn Granuloma annulare: another manifestation of Bartonella infection? Am J Dermatopathol 23 2001 510 513 (Pubitemid 33086478)
40. C.L. Koening, J.C. Miller, J.M. Nelson, D.M. Ward, J.P. Kushner, and L.K. Bockenstedt Toll-like receptors mediate induction of hepcidin in mice infected with Borrelia burgdorferi Blood 114 2009 1913 1918
41. O.S. Shin, L.S. Miller, R.L. Modlin, S. Akira, S. Uematsu, and L.T. Hu Downstream signals for MyD88-mediated phagocytosis of Borrelia burgdorferi can be initiated by TRIF and are dependent on PI3K J Immunol 183 2009 491 498
42. M.M. Petzke, A. Brooks, M.A. Krupna, D. Mordue, and I. Schwartz Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells J Immunol 183 2009 5279 5292
43. H.M. Algood, P.L. Lin, and J.L. Flynn Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis Clin Infect Dis 41 Suppl 2005 S189 S193
44. B. Jurgens, U. Hainz, D. Fuchs, T. Felzmann, and A. Heitger Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells Blood 114 2009 3235 3243
45. J.C. O'Connor, C. Andre, Y. Wang, M.A. Lawson, S.S. Szegedi, and J. Lestage Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin J Neurosci 29 2009 4200 4209
46. Y.I. Jeong, S.W. Kim, I.D. Jung, J.S. Lee, J.H. Chang, and C.M. Lee Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells J Biol Chem 284 2009 3700 3708
47. P. Puccetti, and U. Grohmann IDO and regulatory T cells: a role for reverse signaling and non-canonical NF-kappaB activation Nat Rev Immunol 7 2007 817 823 (Pubitemid 47480306)
48. D.L. Thibault, K.L. Graham, L.Y. Lee, I. Balboni, P.J. Hertzog, and P.J. Utz Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus Arthritis Res Ther 11 2009 R112
49. B. Widner, N. Sepp, E. Kowald, U. Ortner, B. Wirleitner, and P. Fritsch Enhanced tryptophan degradation in systemic lupus erythematosus Immunobiology 201 2000 621 630 (Pubitemid 30242927)
50. B. Maneglier, C. Rogez-Kreuz, O. Spreux-Varoquaux, B. Malleret, P. Therond, and B. Samah Comparative effects of two type I interferons, human IFN-alpha and ovine IFN-tau on indoleamine-2,3-dioxygenase in primary cultures of human macrophages Fundam Clin Pharmacol 21 2007 29 34 (Pubitemid 46096180)
51. C.N. Nagineni, K. Pardhasaradhi, M.C. Martins, B. Detrick, and J.J. Hooks Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells Infect Immun 64 1996 4188 4196 (Pubitemid 26318141)
52. A.S. Almeida, P.M. Lago, N. Boechat, R.C. Huard, L.C. Lazzarini, and A.R. Santos Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity J Immunol 183 2009 718 731
53. T. Yang, P. Stark, K. Janik, H. Wigzell, and M.E. Rottenberg SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearance J Immunol 180 2008 4040 4049
54. H.E. Volkman, T.C. Pozos, J. Zheng, J.M. Davis, J.F. Rawls, and L. Ramakrishnan Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium Science 327 2010 466 469
55. T. Zelante, F. Fallarino, F. Bistoni, P. Puccetti, and L. Romani Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host Microbes Infect 11 2009 133 141